Background/Objectives: Small-cell lung cancer (SCLC) is a highly aggressive malignancy with an emerging molecular classification based on the expression of the transcription factors ASCL1, NEUROD1, and POU2F3. The gene discussed is NEUROD1; the disease is small cell lung carcinoma.